GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
3,461
Funds Holding Change
+74
Funds Holding Growth
+2%
Value
$642B
Holding in Top 10
461
Top 10 Change
-87
Top 10 Growth
-16%
Value Growth
+17%
New
199
Increased
1,609
Reduced
1,427
Closed
92
Capital Inflow
$29.9B
Capital Outflow
$18B
Net Capital Flow
+$11.8B
Capital Flow Change
+$13.7B
Calls
$5.43B
Puts
$6.2B
Net Calls
-$770M
Put/Call Ratio
1.14